Mega Genomics Ltd. has announced a delay in the publication of its 2024 Annual Results and the associated Annual Report. The company, listed on the Hong Kong Stock Exchange, stated that the delay is due to ongoing discussions with a potential new auditor. Trading in the company's shares has been suspended since April 1, 2025, and will remain so until further notice. The company aims to dispatch the necessary Circular to shareholders as soon as practicable.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mega Genomics Ltd. published the original content used to generate this news brief on June 10, 2025, and is solely responsible for the information contained therein.